Stock Analysis

KRX Growth Companies With High Insider Ownership August 2024

KOSE:A352820
Source: Shutterstock

The South Korea stock market has recently experienced volatility, with the KOSPI index showing mixed performances amid broader global economic uncertainties and key inflation data releases. Despite this turbulence, identifying growth companies with high insider ownership can provide valuable insights into potential investment opportunities, as these firms often benefit from strong internal confidence and alignment of interests between management and shareholders.

Top 10 Growth Companies With High Insider Ownership In South Korea

NameInsider OwnershipEarnings Growth
People & Technology (KOSDAQ:A137400)16.5%35.6%
Seojin SystemLtd (KOSDAQ:A178320)30.9%52.1%
Bioneer (KOSDAQ:A064550)17.5%97.6%
Global Tax Free (KOSDAQ:A204620)20.9%78.5%
ALTEOGEN (KOSDAQ:A196170)26.6%99.5%
Oscotec (KOSDAQ:A039200)26.3%122%
Vuno (KOSDAQ:A338220)19.5%110.9%
HANA Micron (KOSDAQ:A067310)21.3%106.2%
UTI (KOSDAQ:A179900)33.1%122.7%
Techwing (KOSDAQ:A089030)18.7%83.6%

Click here to see the full list of 88 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Let's dive into some prime choices out of the screener.

JUSUNG ENGINEERINGLtd (KOSDAQ:A036930)

Simply Wall St Growth Rating: ★★★★★☆

Overview: JUSUNG ENGINEERING Co.,Ltd. manufactures and sells semiconductor, display, solar, and lighting equipment in South Korea and internationally, with a market cap of ₩1.27 billion.

Operations: The company's revenue primarily comes from semiconductor equipment and services, amounting to ₩272.61 billion.

Insider Ownership: 37.1%

JUSUNG ENGINEERING Ltd. exemplifies a growth company with high insider ownership in South Korea, benefiting from strong earnings and revenue forecasts. Analysts predict annual earnings growth of 35.7% and revenue growth of 25.9%, both outpacing the broader market. Despite lower profit margins this year (14.6%) compared to last year (23%), the stock trades at 46.3% below its estimated fair value, suggesting potential for significant price appreciation based on analyst consensus.

KOSDAQ:A036930 Ownership Breakdown as at Aug 2024
KOSDAQ:A036930 Ownership Breakdown as at Aug 2024

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc., a biotechnology company, specializes in creating long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with a market cap of ₩16.76 trillion.

Operations: The company's revenue is primarily derived from its biotechnology segment, which generated ₩90.79 billion.

Insider Ownership: 26.6%

ALTEOGEN is forecast to become profitable within 3 years, with revenue expected to grow at 64.2% annually, significantly outpacing the market. The recent MFDS approval of Tergase® underscores its innovative edge and commercial potential. Despite high share price volatility and past shareholder dilution, its Return on Equity is projected to be very high in 3 years (66.3%). Trading at 75.6% below fair value suggests potential for substantial upside based on analyst estimates.

KOSDAQ:A196170 Ownership Breakdown as at Aug 2024
KOSDAQ:A196170 Ownership Breakdown as at Aug 2024

HYBE (KOSE:A352820)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management with a market cap of ₩7.81 trillion.

Operations: HYBE generates revenue from three primary segments: Label (₩1.28 trillion), Platform (₩361.12 billion), and Solution (₩1.24 trillion).

Insider Ownership: 32.5%

HYBE Co., Ltd. is a growth company with high insider ownership, recently announcing a share repurchase program aimed at stabilizing its stock price. Despite a significant drop in net income for the second quarter of 2024 compared to the previous year, analysts forecast earnings to grow significantly over the next three years. Trading at 18.1% below fair value and expected to outpace market revenue growth, HYBE remains a strong contender in South Korea's market landscape.

KOSE:A352820 Earnings and Revenue Growth as at Aug 2024
KOSE:A352820 Earnings and Revenue Growth as at Aug 2024

Where To Now?

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if HYBE might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com